BR112015022134A2 - composto, composição farmacêutica, adesivo, bastão, dispensador de spray, tubo ou caneta, e, método de tratamento de uma infecção - Google Patents

composto, composição farmacêutica, adesivo, bastão, dispensador de spray, tubo ou caneta, e, método de tratamento de uma infecção

Info

Publication number
BR112015022134A2
BR112015022134A2 BR112015022134A BR112015022134A BR112015022134A2 BR 112015022134 A2 BR112015022134 A2 BR 112015022134A2 BR 112015022134 A BR112015022134 A BR 112015022134A BR 112015022134 A BR112015022134 A BR 112015022134A BR 112015022134 A2 BR112015022134 A2 BR 112015022134A2
Authority
BR
Brazil
Prior art keywords
compound
pharmaceutical composition
patch
pen
stick
Prior art date
Application number
BR112015022134A
Other languages
English (en)
Inventor
Bergman Jan
Homman Mohammed
Kingi Ngarita
Berg Robert
Original Assignee
Vironova Herpes Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vironova Herpes Ab filed Critical Vironova Herpes Ab
Publication of BR112015022134A2 publication Critical patent/BR112015022134A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)

Abstract

1 / 1 resumo “composto, composiã‡ãƒo farmacãšutica, adesivo, bastãƒo, dispensador de spray, tubo ou caneta, e, mã‰todo de tratamento de uma infecã‡ãƒo” ㉠descrito um composto da fã³rmula (i) usado no tratamento de uma infecã§ã£o viral por herpes. uma composiã§ã£o farmacãªutica compreendendo o composto da fã³rmula (i).
BR112015022134A 2013-03-15 2014-03-14 composto, composição farmacêutica, adesivo, bastão, dispensador de spray, tubo ou caneta, e, método de tratamento de uma infecção BR112015022134A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361788867P 2013-03-15 2013-03-15
PCT/EP2014/055178 WO2014140321A1 (en) 2013-03-15 2014-03-14 Antiviral indolo[2,3-b]quinoxaline

Publications (1)

Publication Number Publication Date
BR112015022134A2 true BR112015022134A2 (pt) 2017-07-18

Family

ID=50280403

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112015022134A BR112015022134A2 (pt) 2013-03-15 2014-03-14 composto, composição farmacêutica, adesivo, bastão, dispensador de spray, tubo ou caneta, e, método de tratamento de uma infecção

Country Status (16)

Country Link
US (1) US20160031889A1 (pt)
EP (1) EP2970292A1 (pt)
JP (1) JP2016510798A (pt)
KR (1) KR20150130463A (pt)
CN (1) CN105102459A (pt)
AU (1) AU2014230133A1 (pt)
BR (1) BR112015022134A2 (pt)
CA (1) CA2904468A1 (pt)
CL (1) CL2015002730A1 (pt)
EA (1) EA201500942A1 (pt)
HK (1) HK1220196A1 (pt)
IL (1) IL241364A0 (pt)
MX (1) MX2015011387A (pt)
SG (1) SG11201507310VA (pt)
WO (1) WO2014140321A1 (pt)
ZA (1) ZA201507151B (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4164649A1 (en) * 2020-06-10 2023-04-19 Cyxone AB New use of rabeximod
WO2022002898A1 (en) * 2020-06-29 2022-01-06 Vironova Medical Ab 6h-indolo(2,3-b)quinoxaline derivatives useful in therapy in particular in a virus infection
WO2022058614A1 (en) 2020-09-21 2022-03-24 Vironova Medical Ab Thionoester-derivative of rabeximod for the treatment of inflammatory and autoimmune disorders
US11643415B1 (en) * 2021-12-09 2023-05-09 Cyxone Ab Rabeximod compounds

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE527639C2 (sv) * 2004-06-17 2006-05-02 Oxypharma Ab Alkylsubstituerade indolokinoxaliner

Also Published As

Publication number Publication date
EP2970292A1 (en) 2016-01-20
CN105102459A (zh) 2015-11-25
ZA201507151B (en) 2017-01-25
AU2014230133A1 (en) 2015-11-05
EA201500942A1 (ru) 2016-03-31
HK1220196A1 (zh) 2017-04-28
US20160031889A1 (en) 2016-02-04
KR20150130463A (ko) 2015-11-23
SG11201507310VA (en) 2015-10-29
MX2015011387A (es) 2016-06-10
JP2016510798A (ja) 2016-04-11
WO2014140321A1 (en) 2014-09-18
IL241364A0 (en) 2015-11-30
CL2015002730A1 (es) 2016-07-01
CA2904468A1 (en) 2014-09-18

Similar Documents

Publication Publication Date Title
PE20151867A1 (es) Polipeptidos f de prefusion del virus sincicial respiratorio (rsv )solubles y estabilizados
UY37271A (es) Composiciones nasales de cannabinoides
CY1122189T1 (el) Ιονικες υδατικες συνθεσεις
CY1121928T1 (el) Φαρμακευτικη συνθεση υδροχλωρικης s-κεταμινης
BR112018071585A2 (pt) formulações de um inibidor de lsd1
EA201290131A1 (ru) Производные пурина или деазапурина для применения при лечении вирусных инфекций и других заболеваний
NZ733174A (en) Quinazoline derivatives used to treat hiv
CL2015001864A1 (es) Compuestos derivados de espiropirido[1,2-a]pirazina sustituidos, como inhibidores de la integrasa del vih; composicion farmaceutica que los comprende; y su uso para la profilaxis o el tratamiento de una infeccion por vih.
BR112018075140A2 (pt) composição na forma de uma solução aquosa injetável, e, formulação de dose única a um ph de 7 a 7,8
BR112017002053A2 (pt) composto de acordo com a fórmula (i), composição farmacêutica, e usos de um composto
BR112016020199A8 (pt) composto inibidor de calicreína plasmática de humano, composição farmacêutica compreendendo o referido composto, kit e seu uso
CU20150096A7 (es) Compuestos de amida y composición farmacéutica para el tratamiento de vih
BR112018009009A8 (pt) terapia combinada de um inibidor de formação de capsídeo hbv e um interferon
UY35391A (es) Acido 2-aza-biciclo[2.2.1]heptano-3-carboxilico (bencil-cianometil)-amidas sustituidas inhibidores de catepsina c
UA116648C2 (uk) Фумарати як проліки та їх застосування при лікуванні різних захворювань
EA201791916A1 (ru) 2'-замещенные карбануклеозидные аналоги для противовирусного лечения
MX2022009352A (es) Sal de hemisulfato de nucleotido para el tratamiento del virus de hepatitis c.
CL2013000713A1 (es) Compuestos pirazin-2-cabonil-imino-1,3,8-triaza-espiro-[4.5]-decan-sustituidos, bloqueadores del canal de sodio epitelial (enac); composicion farmaceutica que los incluye; metodo de prevencion o tratamiento; y su uso para tratar una enfermedad o condicion mediada por el bloqueo del canal de sodio epitelial.
CL2008001123A1 (es) Compuestos derivados de acido lipoico; formulacion farmaceutica que lo comprende; y uso en el tratamiento del cancer.
BR112015013695A2 (pt) composição farmacêutica, e, métodos para tratamento e para prevenção de uma infecção por hiv
EA202191513A1 (ru) Снижение вязкости фармацевтических составов
PE20160012A1 (es) Tratamiento de enfermedades miopaticas y neurogenerativas por agregacion de proteina mediante administracion parenteral
BR112017000246A2 (pt) composto, sal farmaceuticamente aceitável de um composto, composição farmacêutica, e, uso de um composto ou de um sal
BR112017000730B8 (pt) Derivados de pirrolidinona como inibidores de metap-2, e medicamentos
BR112015022134A2 (pt) composto, composição farmacêutica, adesivo, bastão, dispensador de spray, tubo ou caneta, e, método de tratamento de uma infecção

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]